N. prodotti: 0
Totale ordine: € 0,00
Official Journal of the , , , ,
In association with
Indexed/Abstracted in: CINAHL, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,063
Online ISSN 1973-9095
Yavuzer G. 1,2, Senel A. 3, Atay M. B. 1, Stam H. J. 2
1 Department of Physical Medicine and Rehabilitation Ankara University Faculty of Medicine, Ankara, Turkey
2 Department of Rehabilitation Medicine Erasmus Medical Center Erasmus University Ankara, Turkey
3 Department of Industrial Technology Golbasi Industrial Arts Education Faculty Gazi University, Ankara, Turkey
Aim. To evaluate the effects of “Playstation EyeToy Games” on upper extremity motor recovery and upper extremity-related motor functioning of patients with subacute stroke.
Methods. The authors designed a randomized, controlled, assessor-blinded, 4-week trial, with follow-up at 3 months. A total of 20 hemiparetic inpatients (mean age 61.1 years), all within 12 months post-stroke, received 30 minutes of treatment with “Playstation EyeToy Games” per day, consisting of flexion and extension of the paretic shoulder, elbow and wrist as well as abduction of the paretic shoulder or placebo therapy (watching the games for the same duration without physical involvement into the games) in addition to conventional program, 5 days a week, 2-5 hours/day for 4 weeks. Brunnstrom’s staging and self-care sub-items of the functional independence measure (FIM) were performed at 0 month (baseline), 4 weeks (post-treatment), and 3 months (follow-up) after the treatment.
Results. The mean change score (95% confidence interval) of the FIM self-care score (5.5 [2.9-8.0] vs 1.8 [0.1-3.7], P=0.018) showed significantly more improvement in the EyeToy group compared to the control group. No significant differences were found between the groups for the Brunnstrom stages for hand and upper extremity.
Conclusion. “Playstation EyeToy Games” combined with a conventional stroke rehabilitation program have a potential to enhance upper extremity-related motor functioning in subacute stroke patients.